Geriatric oncology and clinical trials

Area of Science:

• Geriatric oncology
• Clinical trial design

Background:

• The global population is aging, leading to a rise in older adults diagnosed with cancer.
• Older cancer patients have unique physiological and psychosocial needs distinct from younger individuals.
• Current cancer clinical trials inadequately represent older patients, limiting evidence-based treatment decisions for this demographic.

Purpose of the Study:

• To highlight the critical need for inclusive and tailored clinical trials for the growing population of older cancer patients.
• To identify specific challenges and necessary modifications for improving the enrollment and meaningful data collection from older adults in cancer research.

Main Methods:

• Review of existing literature and clinical trial structures concerning older adult participation in cancer research.
• Analysis of specific geriatric considerations relevant to clinical trial design, eligibility criteria, and outcome measures.

Main Results:

• Older patients are under-represented in cancer clinical trials due to restrictive eligibility criteria and trial designs not accommodating comorbidities, polypharmacy, or specific geriatric endpoints.
• Existing trial endpoints (e.g., progression-free survival) may not fully capture the impact of cancer treatments on older adults' quality of life, function, and independence.

Conclusions:

• Cancer clinical trials must be redesigned to be more inclusive of older patients, incorporating geriatric assessments and patient-specific endpoints.
• Tailored trial designs, including modified eligibility criteria and relevant outcome measures, are essential for generating meaningful data and improving cancer care for the aging population.